A real-world assessment of PIK3CA testing and alpelisib treatment patterns among metastatic breast cancer patients in a community oncology setting

被引:0
|
作者
O'Shaughnessy, Joyce
Paulson, Steven
Brisbin, Lorraine
Lindsey, James
Williford, Anna
Lisi, Monica
Parikh, Rohan C.
Simmons, Stacey
Balu, Sanjeev
机构
关键词
D O I
10.1158/1538-7445.SABCS21-P5-13-16
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5-13-16
引用
收藏
页数:3
相关论文
共 50 条
  • [21] PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
    Pepe, Francesco
    Venetis, Konstantinos
    Cursano, Giulia
    Frascarelli, Chiara
    Pisapia, Pasquale
    Vacirca, Davide
    Scimone, Claudia
    Rappa, Alessandra
    Russo, Gianluca
    Mane, Eltjona
    Pagni, Fabio
    Castellano, Isabella
    Troncone, Giancarlo
    Angelis, Carmine De
    Curigliano, Giuseppe
    Guerini-Rocco, Elena
    Malapelle, Umberto
    Fusco, Nicola
    PHARMACOGENOMICS, 2024, 25 (03) : 161 - 169
  • [22] PIK3CA Mutation Assessment in HR+/HER2-Metastatic Breast Cancer: Overview for Oncology Clinical Practice
    Criscitiello, Carmen
    Marra, Antonio
    Curigliano, Giuseppe
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (01): : 42 - 54
  • [23] Natural history and outcome of patients presenting a metastatic breast cancer with PIK3CA mutation
    Mosele, Fernanda
    Verret, Benjamin
    Lusque, Amelie
    Filleron, Thomas
    Bachelot, Thomas
    Arnedos, Monica
    Campone, Mario
    Dalenc, Florence
    Lefeuvre, Claudia
    Sablin, Marie Paule
    Bonnefoi, Herve
    Lacroix, Ludovic
    Bieche, Ivan
    Goncalves, Anthony
    Jacot, William
    Jimenez, Marta
    Jacquet, Amelie
    Andre, Fabrice
    Andre, Fabrice
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Comparison of real-world mortality data among patients with glioblastoma (GBM) and metastatic pancreatic cancer (mPC) treated in the community oncology setting
    Cosgrove, David
    Aguilar, Kathleen
    Wang, Yunfei
    Sykes, Charles
    Reinwald, Sarah
    Kubisiak, Emily
    Su, Zhaohui
    Chandrasekaran, Vasu
    Stees, Larisa
    Iyer, Rupa
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] REAL-WORLD BIOMARKER PREVALENCE AND TREATMENT PATTERNS AMONG METASTATIC COLORECTAL CANCER PATIENTS WHO UNDERWENT NGS TESTING
    Shao, C.
    Desai, K.
    Li, S.
    Hair, G. M.
    Liu, L.
    Chen, C.
    Groisberg, R.
    Amonkar, M.
    VALUE IN HEALTH, 2024, 27 (06) : S186 - S186
  • [26] Real-world patterns of biomarker testing and targeted therapy in metastatic non-small cell lung cancer (mNSCLC) in the community oncology setting.
    Nadler, Eric S.
    Vasudevan, Anupama
    Davies, Kalatu
    Wang, Yunfei
    Gupta, Ravindra
    Ogale, Sarika
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe
    Castro, Elena
    Orji, Chinelo
    Ribbands, Amanda
    Butcher, Jake
    Walley, Maria
    Li, Weiyan
    Ghate, Sameer R.
    FUTURE ONCOLOGY, 2025,
  • [28] A real-world evidence study of treatment patterns among patients with HER2-positive metastatic breast cancer
    Collins, Jenna
    Nordstrom, Beth
    Kwong, Jackie
    Murphy, Brian
    Pavilack, Melissa
    CANCER RESEARCH, 2021, 81 (04)
  • [29] Real-world treatment patterns and outcomes among elderly metastatic triple negative breast cancer patients in the United States
    Satram-Hoang, S.
    Bajaj, P.
    Stein, A.
    Hoang, K. Q.
    Momin, F.
    Cortazar, P.
    Reyes, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Real-world treatment patterns in patients with metastatic colorectal cancer in the Netherlands
    Elferink, M. A. G.
    van Erning, F. N.
    Sijtsma, F. P. C.
    Valkenburg-van Iersel, L. B.
    Wumkes, M. L.
    Roodhart, J. M. L.
    Vink, G. R.
    ANNALS OF ONCOLOGY, 2024, 35 : S34 - S35